Clinical Trial Update: The Effect of Huperzine A Injection on Postoperative Cognitive Dysfunction in Patients With Aneurysmal Subarachnoid Hemorrhage: a Pilot Study [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating huperzine A injection for postoperative cognitive dysfunction in patients with aneurysmal subarachnoid hemorrhage. Status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Cognitive Dysfunction in Patients with Aneurysmal Subarachnoid Hemorrhage

Drugs mentioned

• Huperzine A (Huperzine A)

Snippet

Sponsor: Wanbangde Pharmaceutical Group Co., LTD | Conditions: Postoperative Cognitive Dysfunction in Patients With Aneurysmal Subarachnoid Hemorrhage | Phase 4 | Status: UNKNOWN